173 related articles for article (PubMed ID: 21039794)
1. Relationship between equine herpesvirus-1 myeloencephalopathy and viral genotype.
Pronost S; Cook RF; Fortier G; Timoney PJ; Balasuriya UB
Equine Vet J; 2010 Nov; 42(8):672-4. PubMed ID: 21039794
[No Abstract] [Full Text] [Related]
2. Neuropathogenic and non-neuropathogenic variants of equine herpesvirus 1 in France.
Pronost S; Léon A; Legrand L; Fortier C; Miszczak F; Freymuth F; Fortier G
Vet Microbiol; 2010 Oct; 145(3-4):329-33. PubMed ID: 20427133
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterisation of equid alphaherpesvirus 1 strains isolated from aborted fetuses in Poland.
Matczuk AK; Skarbek M; Jackulak NA; Bażanów BA
Virol J; 2018 Dec; 15(1):186. PubMed ID: 30509297
[TBL] [Abstract][Full Text] [Related]
4. A single-nucleotide polymorphism in a herpesvirus DNA polymerase is sufficient to cause lethal neurological disease.
Van de Walle GR; Goupil R; Wishon C; Damiani A; Perkins GA; Osterrieder N
J Infect Dis; 2009 Jul; 200(1):20-5. PubMed ID: 19456260
[TBL] [Abstract][Full Text] [Related]
5. Equine herpesvirus myeloencephalopathy: unravelling the enigma.
Nugent J; Paillot R
Vet J; 2009 Jun; 180(3):271-2. PubMed ID: 19141371
[No Abstract] [Full Text] [Related]
6. Detection of EHV-1 neuropathogenic strains using real-time PCR in the neural tissue of horses with myeloencephalopathy.
Leutenegger CM; Madigan JE; Mapes S; Thao M; Estrada M; Pusterla N
Vet Rec; 2008 May; 162(21):688-90. PubMed ID: 18503069
[No Abstract] [Full Text] [Related]
7. Development of a new primer-probe energy transfer method for the differentiation of neuropathogenic and non-neuropathogenic strains of equine herpesvirus-1.
Malik P; Pálfi V; Bálint A
J Virol Methods; 2010 Nov; 169(2):425-7. PubMed ID: 20709107
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the prevalence of neurologic equine herpes virus type 1 (EHV-1) in a 23-year retrospective analysis (1984-2007).
Perkins GA; Goodman LB; Tsujimura K; Van de Walle GR; Kim SG; Dubovi EJ; Osterrieder N
Vet Microbiol; 2009 Nov; 139(3-4):375-8. PubMed ID: 19615831
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.
Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N
Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350
[TBL] [Abstract][Full Text] [Related]
10. Equine herpesvirus neurological disease.
Gilkerson JR; Barrett EJ
Equine Vet J; 2008 Mar; 40(2):102-3. PubMed ID: 18302993
[No Abstract] [Full Text] [Related]
11. Investigation of the role of mules as silent shedders of EHV-1 during an outbreak of EHV-1 myeloencephalopathy in California.
Pusterla N; Mapes S; Wademan C; White A; Estell K; Swain E
Vet Rec; 2012 May; 170(18):465. PubMed ID: 22472540
[No Abstract] [Full Text] [Related]
12. Experimental infection with neuropathogenic equid herpesvirus type 1 (EHV-1) in adult horses.
Goehring LS; van Maanen C; Berendsen M; Cullinane A; de Groot RJ; Rottier PJ; Wesselingh JJ; Sloet van Oldruitenborgh-Oosterbaan MM
Vet J; 2010 Nov; 186(2):180-7. PubMed ID: 19726209
[TBL] [Abstract][Full Text] [Related]
13. Identification of a New Equid Herpesvirus 1 DNA Polymerase (ORF30) Genotype with the Isolation of a C
Sutton G; Thieulent C; Fortier C; Hue ES; Marcillaud-Pitel C; Pléau A; Deslis A; Guitton E; Paillot R; Pronost S
Viruses; 2020 Oct; 12(10):. PubMed ID: 33066315
[TBL] [Abstract][Full Text] [Related]
14. The first reported outbreak of equine herpesvirus myeloencephalopathy in New Zealand.
McFadden AM; Hanlon D; McKenzie RK; Gibson I; Bueno IM; Pulford DJ; Orr D; Dunowska M; Stanislawek WL; Spence RP; McDonald WL; Munro G; Mayhew IG
N Z Vet J; 2016 Mar; 64(2):125-34. PubMed ID: 26414406
[TBL] [Abstract][Full Text] [Related]
15. Neuropathogenic and non-neuropathogenic genotypes of Equid Herpesvirus type 1 in Argentina.
Vissani MA; Becerra ML; Olguín Perglione C; Tordoya MS; Miño S; Barrandeguy M
Vet Microbiol; 2009 Nov; 139(3-4):361-4. PubMed ID: 19589651
[TBL] [Abstract][Full Text] [Related]
16. Equine herpesvirus-1 myeloencephalopathy: a review of recent developments.
Pusterla N; David Wilson W; Madigan JE; Ferraro GL
Vet J; 2009 Jun; 180(3):279-89. PubMed ID: 18805030
[TBL] [Abstract][Full Text] [Related]
17. Antiherpetic Drugs in Equine Medicine.
Maxwell LK
Vet Clin North Am Equine Pract; 2017 Apr; 33(1):99-125. PubMed ID: 28325183
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky.
Allen GP; Bolin DC; Bryant U; Carter CN; Giles RC; Harrison LR; Hong CB; Jackson CB; Poonacha K; Wharton R; Williams NM
Equine Vet J; 2008 Mar; 40(2):105-10. PubMed ID: 18089469
[TBL] [Abstract][Full Text] [Related]
19. Translation of a laboratory-validated equine herpesvirus-1 specific real-time PCR assay into an insulated isothermal polymerase chain reaction (iiPCR) assay for point-of-need diagnosis using POCKIT™ nucleic acid analyzer.
Balasuriya UB; Lee PA; Tsai YL; Tsai CF; Shen YH; Chang HG; Skillman A; Wang HT; Pronost S; Zhang Y
J Virol Methods; 2017 Mar; 241():58-63. PubMed ID: 27993615
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of equine herpesvirus-1 and equine herpesvirus-4 infections in equidae species in Turkey as determined by ELISA and multiplex nested PCR.
Ataseven VS; Dağalp SB; Güzel M; Başaran Z; Tan MT; Geraghty B
Res Vet Sci; 2009 Apr; 86(2):339-44. PubMed ID: 18649902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
